Article thumbnail

Factors influencing acute infusion reactions in inflammatory bowel disease patients treated with infliximab in the era of scheduled maintenance therapy

By Cédric Duron, Marion Goutte, Bruno Pereira, Gilles Bommelaer and Anthony Buisson


Background : An acute infusion reaction during infliximab infusions could lead to drug withdrawal and limit the therapeutic armamentarium in inflammatory bowel diseases Aim : To determine the risk and protective factors of an acute infusion reaction. Materials and methods : Data were retrieved retrospectively from electronic charts of patients from the 'Clermont-Ferrand IBD cohort'. Results : Among 80 patients, including 51 (63.8%) patients with Crohn's disease, 23 (28.8%) experienced an acute infusion reaction. In multivariate analysis, the Crohn's disease nonstricturing nonfistulizing phenotype predicted an acute infusion reaction (odds ratio= 11.40, 95% confidence interval 1.5-87.6; P= 0.019). Among 1107 infusions, we observed 38 acute infusion reactions (3.4%). In multivariate analysis, only resumption of infliximab after drug holiday was a major risk factor (odds ratio= 24.87, 95% confidence interval 4.4-140.0; PConclusion : An acute infusion reaction is a major event in the history of inflammatory bowel diseases patients treated with infliximab as it could lead to drug discontinuation and thus limits the therapeutic armamentarium considerably. The resumption of infliximab after drug holiday is a major risk factor for an acute infusion reaction. Premedication efficacy remains questionable and should be limited to these high-risk patients

Topics: acute infusion reaction, inflammatory bowel disease, risk factor, infliximab, [SDV]Life Sciences [q-bio]
Publisher: 'Ovid Technologies (Wolters Kluwer Health)'
Year: 2015
DOI identifier: 10.1097/MEG.0000000000000354
OAI identifier: oai:HAL:hal-02631408v1
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)
  • Suggested articles

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.